255 related articles for article (PubMed ID: 22720309)
1. Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells.
Tomuleasa C; Soritau O; Orza A; Dudea M; Petrushev B; Mosteanu O; Susman S; Florea A; Pall E; Aldea M; Kacso G; Cristea V; Berindan-Neagoe I; Irimie A
J Gastrointestin Liver Dis; 2012 Jun; 21(2):187-96. PubMed ID: 22720309
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide plus cisplatin/interferon α-2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma.
Tomuleasa C; Soritau O; Fischer-Fodor E; Pop T; Susman S; Mosteanu O; Petrushev B; Aldea M; Acalovschi M; Irimie A; Kacso G
Hematol Oncol Stem Cell Ther; 2011; 4(2):60-6. PubMed ID: 21727766
[TBL] [Abstract][Full Text] [Related]
3. Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells.
Tak E; Lee S; Lee J; Rashid MA; Kim YW; Park JH; Park WS; Shokat KM; Ha J; Kim SS
J Hepatol; 2011 Feb; 54(2):328-39. PubMed ID: 21056497
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis-inducing activity of cisplatin (CDDP) against human hepatoma and oral squamous cell carcinoma cell lines.
Okamura M; Hashimoto K; Shimada J; Sakagami H
Anticancer Res; 2004; 24(2B):655-61. PubMed ID: 15161008
[TBL] [Abstract][Full Text] [Related]
5. Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells.
Villa R; Cerroni B; Viganò L; Margheritelli S; Abolafio G; Oddo L; Paradossi G; Zaffaroni N
Colloids Surf B Biointerfaces; 2013 Oct; 110():434-42. PubMed ID: 23759384
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of combination chemotherapy with capecitabine plus cisplatin in patients with unresectable hepatocellular carcinoma.
Shim JH; Park JW; Nam BH; Lee WJ; Kim CM
Cancer Chemother Pharmacol; 2009 Feb; 63(3):459-67. PubMed ID: 18437384
[TBL] [Abstract][Full Text] [Related]
7. Metformin plus PIAF combination chemotherapy for hepatocellular carcinoma.
Petrushev B; Tomuleasa C; Soritau O; Aldea M; Pop T; Susman S; Kacso G; Berindan I; Irimie A; Cristea V
Exp Oncol; 2012; 34(1):17-24. PubMed ID: 22453143
[TBL] [Abstract][Full Text] [Related]
8. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
[TBL] [Abstract][Full Text] [Related]
9. Effects of paclitaxel and doxorubicin in histocultures of hepatocelular carcinomas.
Chuu JJ; Liu JM; Tsou MH; Huang CL; Chen CP; Wang HS; Chen CT
J Biomed Sci; 2007 Mar; 14(2):233-44. PubMed ID: 17206490
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone decreases hepatocellular carcinoma cell sensitivity to cisplatin-induced apoptosis.
Yang N; Zhang H; Si-Ma H; Fu Y; Zhao W; Li D; Yang G
Hepatogastroenterology; 2011; 58(110-111):1730-5. PubMed ID: 21940343
[TBL] [Abstract][Full Text] [Related]
11. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin sensitizes human hepatocellular carcinoma cells, but not hepatocytes and mesenchymal stem cells, to TRAIL within a therapeutic window partially depending on the upregulation of DR5.
Zhang B; Shan H; Li D; Li ZR; Zhu KS; Jiang ZB; Huang MS
Oncol Rep; 2011 Feb; 25(2):461-8. PubMed ID: 21152876
[TBL] [Abstract][Full Text] [Related]
13. Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma.
Park SH; Lee Y; Han SH; Kwon SY; Kwon OS; Kim SS; Kim JH; Park YH; Lee JN; Bang SM; Cho EK; Shin DB; Lee JH
BMC Cancer; 2006 Jan; 6():3. PubMed ID: 16396674
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS
Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
[TBL] [Abstract][Full Text] [Related]
15. Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma.
Patt YZ; Hassan MM; Aguayo A; Nooka AK; Lozano RD; Curley SA; Vauthey JN; Ellis LM; Schnirer II; Wolff RA; Charnsangavej C; Brown TD
Cancer; 2004 Aug; 101(3):578-86. PubMed ID: 15274071
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
17. [Establishment of a cisplatin-induced human hepatocellular carcinoma drug-resistant cell line and its biological characteristics].
Yang JX; Tang WX
Ai Zheng; 2002 Aug; 21(8):872-6. PubMed ID: 12478896
[TBL] [Abstract][Full Text] [Related]
18. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells.
Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X
Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059
[TBL] [Abstract][Full Text] [Related]
19. Gold nanoparticles generated and stabilized by water soluble curcumin-polymer conjugate: blood compatibility evaluation and targeted drug delivery onto cancer cells.
Manju S; Sreenivasan K
J Colloid Interface Sci; 2012 Feb; 368(1):144-51. PubMed ID: 22200330
[TBL] [Abstract][Full Text] [Related]
20. Recombinant lipoproteins reinforce cytotoxicity of doxorubicin to hepatocellular carcinoma.
Wang B; Yuan Y; Han L; Ye L; Shi X; Feng M
J Drug Target; 2014 Jan; 22(1):76-85. PubMed ID: 24093636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
